HALO logo
halo search icon
SOBI
Swedish Orphan Biovitrum AB

SOBI · Swedish Orphan Biovitrum AB

452.00

SEK
-8.00 (-1.739%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr164.41B

PE

240.70

EV/EBITDA

10.9

DIV Yield

0%

Payout Ratio

0%

MQV Rating

1Very Strong

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The Immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Stockholm, Sweden.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO GARP
  • HALO Growth
  • HALO Momentum
  • HALO MQV

Key Fundamentals

EPS 3 yr Growth

-83.80%

EBITDA Margin

40.90%

Operating Cashflow

kr8,566m

Free Cash Flow Return

17.80%

ROIC

1.00%

Interest Coverage

14.20

Quick Ratio

0.60

Performance

52 weeks range

Low 262.8 - 487

Trade Value (12mth)

US$4,233,808.00

1 week

4.45%

1 month

0.57%

YTD

39.23%

1 year

60.84%

All time high

487.00

Additional Data

Shares Outstanding (Fully Diluted)

350m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Neutral

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Investor AB (Investment Company)Operating Division
AstraZeneca PLCPublic Company
Swedish Orphan Biovitrum ABPublic Company
Guido OelkersIndividual
Sofiane FahmyIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The current share price of Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr452.00.
2
What is the 52-week high share price for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The 52-week high share price for Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr487.00.
3
What is the 52-week low share price for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The 52-week low share price for Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr262.80.
4
What is the dividend yield for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) does not pay a dividend.
5
What was Swedish Orphan Biovitrum AB (SOBI:OME) last dividend payment?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) does not pay a dividend.
6
What is the franking level for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) has a franking level of 0.00%.
7
In which sector is Swedish Orphan Biovitrum AB (SOBI:OME) classified?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The current P/E ratio for Swedish Orphan Biovitrum AB (SOBI:OME) is 240.70.